 Connection
Andrew Bubak to Antiviral Agents
This is a "connection" page, showing publications Andrew Bubak has written about Antiviral Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.676 |
|
|
|
-
Nagel MA, Niemeyer CS, Bubak AN. Central nervous system infections produced by varicella zoster virus. Curr Opin Infect Dis. 2020 06; 33(3):273-278.
Score: 0.439
-
Bubak AN, Como CN, Coughlan CM, Johnson NR, Hassell JE, Mescher T, Niemeyer CS, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Russ HA, Nagel MA. Varicella-Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-ß, and an Amyloidogenic Extracellular Environment. J Infect Dis. 2020 03 16; 221(7):1088-1097.
Score: 0.108
-
Nagel MA, Bubak AN. Varicella Zoster Virus Vasculopathy. J Infect Dis. 2018 09 22; 218(suppl_2):S107-S112.
Score: 0.098
-
Sarkar L, Oko L, Gupta S, Bubak AN, Das B, Gupta P, Safiriyu AA, Singhal C, Neogi U, Bloom D, Banerjee A, Mahalingam R, Cohrs RJ, Koval M, Shindler KS, Pal D, Nagel M, Sarma JD. Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict ß-coronaviral infection and replication. Virology. 2022 04; 569:13-28.
Score: 0.031
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|